Fig. 2

Kaplan–Meier analysis with a log-rank test of survival. Disease-free survival (a) and overall survival (b) were significantly shorter in patients with AGGF1-positive tumors than in those with AGGF1-negative tumors (*p < 0.05 for both, log-rank test). P-values were calculated by log-rank test and p < 0.05 was considered significant